Fiscal Year (FY) 2019 Funding Opportunity, 58779-58780 [2018-25349]

Download as PDF Federal Register / Vol. 83, No. 225 / Wednesday, November 21, 2018 / Notices Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: November 14, 2018. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–25355 Filed 11–20–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Meetings khammond on DSK30JT082PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Conference Grants in Support of Heart, Lung, and Blood Research. Date: December 11–12, 2018. Time: 8:00 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Room 7296, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Stephanie J. Webb, Ph.D., Scientific Review Officer, Office of Scientific Review, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Room 7196, Bethesda, MD 20892, 301–287–7332, stephanie.webb@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: November 15, 2018. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–25353 Filed 11–20–18; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 16:08 Nov 20, 2018 Jkt 247001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Chronic Neurodegenerative Diseases. Date: December 11, 2018. Time: 1:00 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Seetha Bhagavan, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5194, MSC 7846, Bethesda, MD 20892, (301) 237– 9838, bhagavas@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: November 15, 2018. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–25356 Filed 11–20–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Fiscal Year (FY) 2019 Funding Opportunity Substance Abuse and Mental Health Services Administration, HHS. ACTION: Notice of intent to award a single source grant to the Community Anti-Drug Coalitions of America (CADCA). AGENCY: PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 58779 This notice is to inform the public that the Substance Abuse and Mental Health Services Administration (SAMHSA) intends to award $500,000 (total costs) for up to five years to CADCA for the National Anti-Drug Coalitions Training and Workforce Development Grant. Under this initiative, CADCA will provide training to state and community prevention leaders, including members of anti-drug community coalitions from around the country who are committed to addressing the evolving needs of the behavioral health field, and promote workforce development. Training and workforce development activities supported through this grant include SAMHSA’s Prevention Day, the CADCA National Leadership Forum, and CADCA’s Mid-Year Training Institute. These activities aim to disseminate knowledge and transfer state-of-the-art information, assisting state and community leaders in developing and implementing evidence-based programs, practices, and policies aligned with the 21st Century Cures Act, the Comprehensive Addition and Recovery Act, the President’s Commission on combating drug addiction and the opioid crisis, and other national substance abuse prevention goals, outcomes, and efforts, including underage drinking prevention. This is not a formal request for applications. Assistance will be provided only to CADCA based on the receipt of a satisfactory application that is approved by an independent review group. Funding Opportunity Title: SP–19– 002. Catalog of Federal Domestic Assistance (CFDA) Number: 93.243. Authority: Section 516 of the Public Health Services Act, as amended. SUMMARY: Justification Eligibility for this award is limited to CADCA. The purpose of this grant to provide training and workforce development for thousands of members of community coalitions dedicated to preventing substance abuse through a national leadership workforce development and training event. CADCA is the only national organization that has special expertise and unique broad, national-level experience in working with community anti-drug coalitions. For more than 22 years, coalitions and coalition leadership have turned to CADCA to obtain the assistance they need to implement, operate, and sustain effective local community anti-drug strategies. CADCA will take advantage of the resources of multiple agencies located throughout the federal, state and E:\FR\FM\21NON1.SGM 21NON1 58780 Federal Register / Vol. 83, No. 225 / Wednesday, November 21, 2018 / Notices local governments, philanthropies, and universities to bring the best available knowledge, information, and technology to local community anti-drug coalitions working to prevent and reduce drug use among the youth of America. CADCA is the only identified organization with the required experience and national reach to over 5,000 identified anti-drug coalitions across the country. Significant investments were made over the years to support this program with outstanding results. CADCA has long been recognized in communities as well as states throughout the nation for the technical support it has provided to anti-drug coalitions. As such, it is uniquely qualified and positioned to carry out the requirements of this announcement. Contact: Odessa Crocker, Substance Abuse and Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD 20857; telephone: (240) 276–1078; email: Odessa.Crocker@ samhsa.hhs.gov. Dated: November 15, 2018. Carlos Castillo, Committee Management Officer. [FR Doc. 2018–25349 Filed 11–20–18; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG–2018–0792] Collection of Information Under Review by Office of Management and Budget; OMB Control Number: 1625– 0035 Coast Guard, DHS. Thirty-day notice requesting comments. AGENCY: ACTION: In compliance with the Paperwork Reduction Act of 1995 the U.S. Coast Guard is forwarding an Information Collection Request (ICR), to the Office of Management and Budget (OMB), Office of Information and Regulatory Affairs (OIRA), requesting an extension of its approval for a collection of information regarding: 1625–0035, Title 46 CFR Subchapter Q: Lifesaving, Electrical, Engineering and Navigation Equipment, Construction and Materials & Marine Sanitation Devices (33 CFR part 159); without change. Our ICR describes the information we seek to collect from the public. Review and comments by OIRA ensure we only impose paperwork burdens commensurate with our performance of duties. khammond on DSK30JT082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 16:08 Nov 20, 2018 Jkt 247001 Comments must reach the Coast Guard and OIRA on or before December 21, 2018. ADDRESSES: You may submit comments identified by Coast Guard docket number [USCG–2018–0792] to the Coast Guard using the Federal eRulemaking Portal at https://www.regulations.gov. Alternatively, you may submit comments to OIRA using one of the following means: (1) Email: dhsdeskofficer@ omb.eop.gov. (2) Mail: OIRA, 725 17th Street NW, Washington, DC 20503, attention Desk Officer for the Coast Guard. A copy of the ICR is available through the docket on the internet at https:// www.regulations.gov. Additionally, copies are available from: Commandant (CG–612), Attn: Paperwork Reduction Act Manager, U.S. Coast Guard, 2703 Martin Luther King Jr. Ave. SE, STOP 7710, Washington, DC 20593–7710. FOR FURTHER INFORMATION CONTACT: Mr. Anthony Smith, Office of Information Management, telephone 202–475–3532, or fax 202–372–8405, for questions on these documents. SUPPLEMENTARY INFORMATION: In compliance with the Paperwork Reduction Act of 1995 the U.S. Coast Guard is forwarding an ICR to OMB, OIRA, requesting an extension of its approval for a collection of the following information: 1625–0035, Title 46 CFR Subchapter Q Lifesaving, Electrical, Engineering and Navigation Equipment, Construction and Materials & Marine Sanitation Devices (33 CFR part 159) without change. DATES: Public Participation and Request for Comments This Notice relies on the authority of the Paperwork Reduction Act of 1995; 44 U.S.C. Chapter 35, as amended. An ICR is an application to OIRA seeking the approval, extension, or renewal of a Coast Guard collection of information (Collection). The ICR contains information describing the Collection’s purpose, the Collection’s likely burden on the affected public, an explanation of the necessity of the Collection, and other important information describing the Collection. There is one ICR for each Collection. The Coast Guard invites comments on whether this ICR should be granted based on the Collection being necessary for the proper performance of Departmental functions. In particular, the Coast Guard would appreciate comments addressing: (1) The practical utility of the Collection; (2) the accuracy of the estimated burden of the Collection; (3) ways to enhance the PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 quality, utility, and clarity of information subject to the Collection; and (4) ways to minimize the burden of the Collection on respondents, including the use of automated collection techniques or other forms of information technology. These comments will help OIRA determine whether to approve the ICR referred to in this Notice. We encourage you to respond to this request by submitting comments and related materials. Comments to Coast Guard or OIRA must contain the OMB Control Number of the ICR. They must also contain the docket number of this request, [USCG–2018–0792], and must be received by December 21, 2018 Submitting Comments We encourage you to submit comments through the Federal eRulemaking Portal at https:// www.regulations.gov. If your material cannot be submitted using https:// www.regulations.gov, contact the person in the FOR FURTHER INFORMATION CONTACT section of this document for alternate instructions. Documents mentioned in this notice, and all public comments, are in our online docket at https://www.regulations.gov and can be viewed by following that website’s instructions. Additionally, if you go to the online docket and sign up for email alerts, you will be notified when comments are posted. We accept anonymous comments. All comments received will be posted without change to https:// www.regulations.gov and will include any personal information you have provided. For more about privacy and the docket, you may review a Privacy Act notice regarding the Federal Docket Management System in the March 24, 2005, issue of the Federal Register (70 FR 15086). OIRA posts its decisions on ICRs online at https://www.reginfo.gov/ public/do/PRAMain after the comment period for each ICR. An OMB Notice of Action on each ICR will become available via a hyperlink in the OMB Control Number: 1625–0035. Previous Request for Comments This request provides a 30-day comment period required by OIRA. The Coast Guard published the 60-day notice (83 FR 45267, September 6, 2018) required by 44 U.S.C. 3506(c)(2). That notice elicited no comments. Accordingly, no changes have been made to the Collections. Information Collection Request Title: Title 46 CFR Subchapter Q: Lifesaving, Electrical, Engineering and E:\FR\FM\21NON1.SGM 21NON1

Agencies

[Federal Register Volume 83, Number 225 (Wednesday, November 21, 2018)]
[Notices]
[Pages 58779-58780]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-25349]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Fiscal Year (FY) 2019 Funding Opportunity

AGENCY: Substance Abuse and Mental Health Services Administration, HHS.

ACTION: Notice of intent to award a single source grant to the 
Community Anti-Drug Coalitions of America (CADCA).

-----------------------------------------------------------------------

SUMMARY: This notice is to inform the public that the Substance Abuse 
and Mental Health Services Administration (SAMHSA) intends to award 
$500,000 (total costs) for up to five years to CADCA for the National 
Anti-Drug Coalitions Training and Workforce Development Grant. Under 
this initiative, CADCA will provide training to state and community 
prevention leaders, including members of anti-drug community coalitions 
from around the country who are committed to addressing the evolving 
needs of the behavioral health field, and promote workforce 
development. Training and workforce development activities supported 
through this grant include SAMHSA's Prevention Day, the CADCA National 
Leadership Forum, and CADCA's Mid-Year Training Institute. These 
activities aim to disseminate knowledge and transfer state-of-the-art 
information, assisting state and community leaders in developing and 
implementing evidence-based programs, practices, and policies aligned 
with the 21st Century Cures Act, the Comprehensive Addition and 
Recovery Act, the President's Commission on combating drug addiction 
and the opioid crisis, and other national substance abuse prevention 
goals, outcomes, and efforts, including underage drinking prevention. 
This is not a formal request for applications. Assistance will be 
provided only to CADCA based on the receipt of a satisfactory 
application that is approved by an independent review group.
    Funding Opportunity Title: SP-19-002.
    Catalog of Federal Domestic Assistance (CFDA) Number: 93.243.
    Authority: Section 516 of the Public Health Services Act, as 
amended.

Justification

    Eligibility for this award is limited to CADCA. The purpose of this 
grant to provide training and workforce development for thousands of 
members of community coalitions dedicated to preventing substance abuse 
through a national leadership workforce development and training event. 
CADCA is the only national organization that has special expertise and 
unique broad, national-level experience in working with community anti-
drug coalitions. For more than 22 years, coalitions and coalition 
leadership have turned to CADCA to obtain the assistance they need to 
implement, operate, and sustain effective local community anti-drug 
strategies. CADCA will take advantage of the resources of multiple 
agencies located throughout the federal, state and

[[Page 58780]]

local governments, philanthropies, and universities to bring the best 
available knowledge, information, and technology to local community 
anti-drug coalitions working to prevent and reduce drug use among the 
youth of America. CADCA is the only identified organization with the 
required experience and national reach to over 5,000 identified anti-
drug coalitions across the country. Significant investments were made 
over the years to support this program with outstanding results. CADCA 
has long been recognized in communities as well as states throughout 
the nation for the technical support it has provided to anti-drug 
coalitions. As such, it is uniquely qualified and positioned to carry 
out the requirements of this announcement.
    Contact: Odessa Crocker, Substance Abuse and Mental Health Services 
Administration, 5600 Fishers Lane, Rockville, MD 20857; telephone: 
(240) 276-1078; email: [email protected].

    Dated: November 15, 2018.
Carlos Castillo,
Committee Management Officer.
[FR Doc. 2018-25349 Filed 11-20-18; 8:45 am]
BILLING CODE 4162-20-P